Search Results - "immunogenicity"

A Randomized, Double-Blind, Parallel-Controlled Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of SCT510 to Bevacizumab (Avastin®) in Healthy Chinese Males by Jing Wu, Guolan Wu, Liangzhi Xie, Duo Lv, Chang Xu, Huili Zhou, Lihua Wu, Jingjing Zhang, Jianzhong Shentu

Connect to this object online.

Safety and immunogenicity of booster vaccination and fractional dosing with Ad26.COV2.S or BNT162b2 in Ad26.COV2.S-vaccinated participants. by Catherine Riou, Jinal N Bhiman, Yashica Ganga, Shobna Sawry, Frances Ayres, Richard Baguma, Sashkia R Balla, Ntombi Benede, Mallory Bernstein, Asiphe S Besethi, Sandile Cele, Carol Crowther, Mrinmayee Dhar, Sohair Geyer, Katherine Gill, Alba Grifoni, Tandile Hermanus, Haajira Kaldine, Roanne S Keeton, Prudence Kgagudi, Khadija Khan, Erica Lazarus, Jean Le Roux, Gila Lustig, Mashudu Madzivhandila, Siyabulela F J Magugu, Zanele Makhado, Nelia P Manamela, Qiniso Mkhize, Paballo Mosala, Thopisang P Motlou, Hygon Mutavhatsindi, Nonkululeko B Mzindle, Anusha Nana, Rofhiwa Nesamari, Amkele Ngomti, Anathi A Nkayi, Thandeka P Nkosi, Millicent A Omondi, Ravindre Panchia, Faeezah Patel, Alessandro Sette, Upasna Singh, Strauss van Graan, Elizabeth M Venter, Avril Walters, Thandeka Moyo-Gwete, Simone I Richardson, Nigel Garrett, Helen Rees, Linda-Gail Bekker, Glenda Gray, Wendy A Burgers, Alex Sigal, Penny L Moore, Lee Fairlie

Connect to this object online.

Efficacy, Immunogenicity and Safety of Vaccination in Pediatric Patients With Autoimmune Inflammatory Rheumatic Diseases (pedAIIRD): A Systematic Literature Review for the 2021 Update of the EULAR/PRES Recommendations by Marc H. Jansen, Marc H. Jansen, Christien Rondaan, Geertje Legger, Geertje Legger, Kirsten Minden, Kirsten Minden, Yosef Uziel, Nataša Toplak, Nataša Toplak, Despoina Maritsi, Mirjam van den Berg, Guy Berbers, Patricia Bruijning, Yona Egert, Christophe Normand, Christophe Normand, Marc Bijl, Helen Foster, Isabelle Kone-Paut, Isabelle Kone-Paut, Carine Wouters, Angelo Ravelli, Angelo Ravelli, Ori Elkayam, Nicolaas M. Wulffraat, Nicolaas M. Wulffraat, Marloes W. Heijstek, Marloes W. Heijstek

Connect to this object online.

Immunogenicity of fractional doses of tetravalent a/c/y/w135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda. by Philippe J Guerin, Lisbeth M Naess, Carole Fogg, Einar Rosenqvist, Loretxu Pinoges, Francis Bajunirwe, Carolyn Nabasumba, Ray Borrow, Leif O Frøholm, Salah Ghabri, Vincent Batwala, Rogers Twesigye, Ingeborg S Aaberge, John-Arne Røttingen, Patrice Piola, Dominique A Caugant

Connect to this object online.

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study by Xiaoyuan Huang, Jing Liang, Lili Huang, Xuanxuan Nian, Wei Chen, Jiayou Zhang, Xiao Xu, Xuan Lin, Yue Wang, Jinrong Shi, Lanxin Jia, Qingliang Li, Qianxi Wang, Kai Duan, Xinguo Li, Yaqi Ji, Feixia Peng, Wei Zhang, Zhiqiang Xie, Yanxia Wang, Xiaoming Yang

Connect to this object online.

Sulfated Lactosyl Archaeol Archaeosomes Synergize with Poly(I:C) to Enhance the Immunogenicity and Efficacy of a Synthetic Long Peptide-Based Vaccine in a Melanoma Tumor Model by Bassel Akache, Gerard Agbayani, Felicity C. Stark, Yimei Jia, Renu Dudani, Blair A. Harrison, Lise Deschatelets, Vandana Chandan, Edmond Lam, Usha D. Hemraz, Sophie Régnier, Lakshmi Krishnan, Michael J. McCluskie

Connect to this object online.

A multicenter phase IV study to investigate the immunogenicity of recombinant human follicle-stimulating hormone and its impact on clinical outcomes in females undergoing controlled ovarian stimulation by Abha Majumdar, Le Hoang, Ly T Loc, Padma Srivastava, Chitra Ramamurthy, Ratnabali Chakravorty, Yogeshwar S Nandanwar, M D Rashmi, Rahul V Mayekar, Jayashree Sridhar, Ganesh H Divekar, James John

Connect to this object online.

Segmental dilatation of ileum in a child with juvenile idiopathic arthritis, localized myopathy with focal stasis induced immunogenic injury as a possible etiology: a case report by Santosh Kumar Mahalik, Susama Patra, Bikasha Bihary Tripathy, Akash Bihari Pati, Manoj Kumar Mohanty, Subash Chandra Samal

Connect to this object online.

Immunogenicity of RV1 and RV5 vaccines administered in standard and interchangeable mixed schedules: a randomized, double-blind, non-inferiority clinical trial in Mexican infants by Mercedes Macías-Parra, Patricia Vidal-Vázquez, Jesús Reyna-Figueroa, Miguel Ángel Rodríguez-Weber, Hortensia Moreno-Macías, Inés Hernández-Benavides, Sofía Fortes-Gutiérrez, Vesta Louise Richardson, Paola Vázquez-Cárdenas

Connect to this object online.

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial by Dapeng Sun, Dan Yu, Zhenhua Du, Ningning Jia, Xiaodong Liu, Jianwen Sun, Qing Xu, Zhuoqun Sun, Chunfang Luan, Jingjing Lv, Ping Xiong, Li Zhang, Xueyan Sha, Yongjun Gao, Dianmin Kang

Connect to this object online.

Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia by I. V. Dolzhikova, O. V. Zubkova, A. I. Tukhvatulin, A. S. Dzharullaeva, N. M. Tukhvatulina, D. V. Shcheblyakov, M. M. Shmarov, E. A. Tokarskaya, Y. V. Simakova, D. A. Egorova, D. N. Scherbinin, I. L. Tutykhina, A. A. Lysenko, A. V. Kostarnoy, P. G. Gancheva, T. A. Ozharovskaya, B. V. Belugin, L. V. Kolobukhina, V. B. Pantyukhov, S. I. Syromyatnikova, I. V. Shatokhina, T. V. Sizikova, I. G. Rumyantseva, A. F. Andrus, N. V. Boyarskaya, A. N. Voytyuk, V. F. Babira, S. V. Volchikhina, D. A. Kutaev, A. N. Bel'skih, K. V. Zhdanov, S. M. Zakharenko, S. V. Borisevich, D. Y. Logunov, B. S. Naroditsky, A. L. Gintsburg

Connect to this object online.

Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial by Anand Prakash Dubey, Mohammad Moonis Akbar Faridi, Monjori Mitra, Iqbal Rajinder Kaur, Aashima Dabas, Jaydeep Choudhury, Mallar Mukherjee, Devendra Mishra

Connect to this object online.

Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study by Feng-Cai Zhu, Yue-Mei Hu, Ya-Nan Li, Jean-Denis Shu, Philipp Oster

Connect to this object online.

Safety and immunogenicity of an upper-range release titer measles-mumps-rubella vaccine in children vaccinated at 12 to 15 months of age: a phase III, randomized study by The MMR-162 Study Group

Connect to this object online.

Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan by Junko Terada-Hirashima, Yuki Takamatsu, Yosuke Shimizu, Yukari Uemura, Junko S. Takeuchi, Noriko Tomita, Kouki Matsuda, Kenji Maeda, Shohei Yamamoto, Ami Fukunaga, Norio Ohmagari, Ayako Mikami, Kengo Sonoda, Mugen Ujiie, Hiroaki Mitsuya, Wataru Sugiura

Connect to this object online.

A randomized trial assessing the efficacy, immunogenicity, and safety of vaccination with live attenuated varicella zoster virus-containing vaccines: ten-year follow-up in Russian children by Leyla Namazova-Baranova, Md Ahsan Habib, Michael Povey, Kamilla Efendieva, Olga Fedorova, Marina Fedoseenko, Tatyana Ivleva, Yulia Kovshirina, Julia Levina, Artem Lyamin, Ludmila Ogorodova, Olga Reshetko, Viktor Romanenko, Inna Ryzhenkova, Irina Sidorenko, Yakov Yakovlev, Aleksandr Zhestkov, Vladimir Tatochenko, Michael Scherbakov, Evgeniy L Shpeer, Giacomo Casabona, on behalf of the OKAH-182 Russia Study Group

Connect to this object online.

Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children: a double-blind, randomized phase III trial by Lili Huang, Zhen Chen, Yuansheng Hu, Zhiqiang Xie, Ping Qiu, Lang Zhu, Manli Bao, Yaru Quan, Ji Zeng, Yanxia Wang, Xiaoyu Cui, Liyong Yuan, Shengli Xia, Fanhong Meng

Connect to this object online.

Schistosoma mansoni Larval Extracellular Vesicle protein 1 (SmLEV1) is an immunogenic antigen found in EVs released from pre-acetabular glands of invading cercariae. by Thomas A Gasan, Marije E Kuipers, Grisial H Roberts, Gilda Padalino, Josephine E Forde-Thomas, Shona Wilson, Jakub Wawrzyniak, Edridah M Tukahebwa, Karl F Hoffmann, Iain W Chalmers

Connect to this object online.

PP 8.1 - 00003 Optimization of the 5' cap and untranslated regions enhances the immunogenicity of an mRNA-based therapeutic vaccine in SIV-infected rhesus macaques on ART by W. Omange, B. Varco-Merth, A. Morenco, M.T. Chaunzwa, C. Nkoy, D. Duell, O. Fadeyi, M. Medina, S. Hoffmeister, W. Goodwin, R. Butler, Z. Etaki, H. Park, J. Smedley, M.K. Axhelm, S. Hansen, J. Lifson, J. Gergen, S. Rauch, B. Petsch, L.J. Picker, A.A. Okoye

Connect to this object online.

Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial by Deborah Watson-Jones, ProfPhD, John Changalucha, MSc, Hilary Whitworth, PhD, Ligia Pinto, PhD, Paul Mutani, MD, Jackton Indangasi, MSc, Troy Kemp, PhD, Ramadhan Hashim, BSc, Beatrice Kamala, Dip, Rebecca Wiggins, PhD, Twaib Songoro, BA, Nicholas Connor, MSc, Gladys Mbwanji, MSc, Miquel A Pavon, PhD, Brett Lowe, MSc, Devis Mmbando, BSc, Saidi Kapiga, ProfPhD, Philippe Mayaud, ProfMD, Silvia de SanJosé, MD, Joakim Dillner, ProfPhD, Richard J Hayes, ProfDSc, Charles J Lacey, ProfMD, Kathy Baisley, MSc

Connect to this object online.